Literature DB >> 12054648

Leptin mediates a proliferative response in human MCF7 breast cancer cells.

Marie-Noelle Dieudonne1, Florence Machinal-Quelin, Valérie Serazin-Leroy, Marie-Christine Leneveu, René Pecquery, Yves Giudicelli.   

Abstract

Obesity is a risk factor of breast cancers. As leptin, a hormone mainly secreted by white adipocytes, elicits proliferative effects in some cell types, we tested the hypothesis that leptin could influence human breast cancer MCF-7 cell growth. Here we show that MCF-7 cells express leptin receptors and respond to human recombinant leptin by STAT3 and p42/p44 MAPkinase activations and by increased proliferation. These findings suggest that leptin could act in vivo as a paracrine/endocrine growth factor towards mammary epithelial cells thus contributing to explain why obesity is a risk factor of developing breast cancers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054648     DOI: 10.1016/S0006-291X(02)00205-X

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  93 in total

Review 1.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

2.  Mammary ductal growth is impaired in mice lacking leptin-dependent signal transducer and activator of transcription 3 signaling.

Authors:  Stephanie R Thorn; Sarah L Giesy; Martin G Myers; Yves R Boisclair
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

Review 3.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

Authors:  Shanchun Guo; Mingli Liu; Guangdi Wang; Marta Torroella-Kouri; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2012-01-24

Review 4.  Leptin--from regulation of fat metabolism to stimulation of breast cancer growth.

Authors:  Mariola Sulkowska; Jolanta Golaszewska; Andrzej Wincewicz; Mariusz Koda; Marek Baltaziak; Stanislaw Sulkowski
Journal:  Pathol Oncol Res       Date:  2006-06-24       Impact factor: 3.201

Review 5.  Impact of obesity on development and progression of mammary tumors in preclinical models of breast cancer.

Authors:  Margot P Cleary
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-12       Impact factor: 2.673

6.  Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.

Authors:  Suman K Samanta; Anuradha Sehrawat; Su-Hyeong Kim; Eun-Ryeong Hahm; Yongli Shuai; Ruchi Roy; Subrata K Pore; Krishna B Singh; Susan M Christner; Jan H Beumer; Nancy E Davidson; Shivendra V Singh
Journal:  J Natl Cancer Inst       Date:  2016-12-31       Impact factor: 13.506

7.  In vivo microdialysis sampling of adipokines CCL2, IL-6, and leptin in the mammary fat pad of adult female rats.

Authors:  Geetika Bajpai; Rosalia C M Simmen; Julie A Stenken
Journal:  Mol Biosyst       Date:  2014-01-24

8.  Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells.

Authors:  Cinzia Giordano; Donatella Vizza; Salvatore Panza; Ines Barone; Daniela Bonofiglio; Marilena Lanzino; Diego Sisci; Francesca De Amicis; Suzanne A W Fuqua; Stefania Catalano; Sebastiano Andò
Journal:  Mol Oncol       Date:  2012-11-23       Impact factor: 6.603

9.  Distinct effects of calorie restriction and exercise on mammary gland gene expression in C57BL/6 mice.

Authors:  Michela Padovani; Jackie A Lavigne; Gadisetti V R Chandramouli; Susan N Perkins; J Carl Barrett; Stephen D Hursting; L Michelle Bennett; David Berrigan
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

10.  Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer.

Authors:  Christos Yapijakis; Michael Kechagiadakis; Emeka Nkenke; Zoe Serefoglou; Dimitrios Avgoustidis; Antonis Vylliotis; Despina Perrea; Friedrich W Neukam; Efstratios Patsouris; Eleftherios Vairaktaris
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-15       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.